Boston Scientific Corp. (BSX)
43.64
+0.61
(+1.42%)
USD |
NYSE |
Nov 18, 16:00
43.45
-0.19
(-0.44%)
Pre-Market: 07:38
Boston Scientific Enterprise Value : 74.78B for Nov. 18, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 74.78B |
| November 17, 2026 | 73.90B |
| November 16, 2026 | 74.86B |
| November 13, 2026 | 75.80B |
| November 12, 2026 | 75.60B |
| November 11, 2026 | 76.94B |
| November 10, 2026 | 76.32B |
| November 09, 2026 | 75.33B |
| November 06, 2026 | 73.49B |
| November 05, 2026 | 76.23B |
| November 04, 2026 | 77.94B |
| November 03, 2026 | 74.58B |
| November 02, 2026 | 75.77B |
| October 30, 2026 | 72.38B |
| October 29, 2026 | 73.41B |
| October 28, 2026 | 73.03B |
| October 27, 2026 | 76.84B |
| October 26, 2026 | 77.60B |
| October 23, 2026 | 77.76B |
| October 22, 2026 | 78.22B |
| October 21, 2026 | 76.04B |
| October 20, 2026 | 77.60B |
| October 19, 2026 | 76.83B |
| October 16, 2026 | 75.87B |
| October 15, 2026 | 75.51B |
| Date | Value |
|---|---|
| October 14, 2026 | 73.86B |
| October 13, 2026 | 74.31B |
| October 12, 2026 | 75.07B |
| October 09, 2026 | 73.46B |
| October 08, 2026 | 72.46B |
| October 07, 2026 | 71.80B |
| October 06, 2026 | 72.68B |
| October 05, 2026 | 72.99B |
| October 02, 2026 | 73.28B |
| October 01, 2026 | 74.19B |
| September 30, 2026 | 74.80B |
| September 29, 2026 | 75.70B |
| September 28, 2026 | 76.03B |
| September 25, 2026 | 75.76B |
| September 24, 2026 | 76.86B |
| September 23, 2026 | 76.77B |
| September 22, 2026 | 77.20B |
| September 21, 2026 | 75.47B |
| September 18, 2026 | 74.92B |
| September 17, 2026 | 75.22B |
| September 16, 2026 | 75.74B |
| September 15, 2026 | 75.68B |
| September 14, 2026 | 77.39B |
| September 11, 2026 | 74.40B |
| September 10, 2026 | 74.57B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 208.41B |
| Becton, Dickinson & Co. | 74.19B |
| Stryker Corp. | 133.28B |
| Insulet Corp. | 10.09B |
| The Cooper Cos., Inc. | 13.94B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 580.00M |
| Revenue (Quarterly) | 5.138B |
| Total Expenses (Quarterly) | 4.556B |
| EPS Diluted (Quarterly) | 0.4008 |
| Gross Profit Margin (Quarterly) | 62.20% |
| Profit Margin (Quarterly) | 11.29% |
| Earnings Yield | 5.41% |
| Operating Earnings Yield | 7.00% |
| Normalized Earnings Yield | 5.844 |